| Literature DB >> 35060107 |
Da In Diane Lee1,2, Shelley Vanderhout1,3, Mary Aglipay1,2, Catherine S Birken2,3,4,5, Shaun K Morris2,5,6, Pierre-Philippe Piché-Renaud2,5,6, Charles D G Keown-Stoneman7,8, Jonathon L Maguire9,10,11,12,13.
Abstract
OBJECTIVES: In many jurisdictions, routine medical care was reduced in response to the COVID-19 pandemic. The objective of this study was to determine whether the frequency of on-time routine childhood vaccinations among children age 0-2 years was lower following the COVID-19 declaration of emergency in Ontario, Canada, on March 17, 2020, compared to prior to the pandemic.Entities:
Keywords: COVID-19; Immunization; Immunization schedule; Vaccination coverage; Vaccinations
Mesh:
Year: 2022 PMID: 35060107 PMCID: PMC8773389 DOI: 10.17269/s41997-021-00601-9
Source DB: PubMed Journal: Can J Public Health ISSN: 0008-4263
Participant characteristics
| All participants, | Participants with vaccination on timea, | Participants with vaccination delayedb, | |
|---|---|---|---|
| Number of individuals | 1277 | 1082 | 880 |
| Date of scheduled vaccinationc | |||
| Before March 17, 2020 | 1242 (76.8%) | 1052 (86.3%) | 785 (78.4%) |
| After March 17, 2020 | 375 (23.2%) | 167 (13.7%) | 216 (21.6%) |
| Sex | |||
| Female | 648 (50.9%) | 546 (50.6%) | 437 (49.8%) |
| Male | 624 (49.1%) | 532 (49.4%) | 440 (50.2%) |
| Maternal ethnicity | |||
| European | 293 (52.0%) | 257 (54.3%) | 185 (48.2%) |
| East Asian | 50 (8.9%) | 45 (9.3%) | 33 (8.6%) |
| South Asian | 63 (11.2%) | 51 (10.8%) | 40 (10.4%) |
| Southeast Asian | 19 (3.4%) | 15 (3.2%) | 15 (3.9%) |
| Arab | 11 (2.0%) | 8 (1.7%) | 8 (2.1%) |
| African | 54 (9.6%) | 37 (7.8%) | 46 (12.0%) |
| Latin American | 26 (4.6%) | 21 (4.4%) | 20 (5.2%) |
| Mixed or other ethnicity | 48 (8.5%) | 40 (8.5%) | 37 (9.6%) |
| Household annual income (self-reported) | |||
| < $40,000 | 43 (8.5%) | 37 (8.6%) | 33 (9.6%) |
| $40,000 to $79,999 | 69 (13.6%) | 49 (11.4%) | 52 (15.2%) |
| $80,000 to $149,999 | 144 (28.5%) | 121 (27.9%) | 93 (27.2%) |
| ≥ $150,000 | 249 (49.4%) | 224 (52.1%) | 164 (48.0%) |
| Maternal education | |||
| High school or public school | 36 (7.1%) | 26 (6.0%) | 24 (7.0%) |
| College or university | 473 (92.9%) | 408 (94.0%) | 320 (93.0%) |
| Household structure | |||
| Two-parent household | 490 (95.3%) | 417 (95.6%) | 333 (96.0%) |
| Single-parent household | 24 (4.7%) | 19 (4.4%) | 14 (4.0%) |
| Distance from clinic (km) | 7.1 (14.5) | 6.7 (11.0) | 7.9 (19.1) |
| Parent-reported health conditiond | |||
| Yes | 107 (24.3%) | 92 (24.6%) | 66 (22.7%) |
| No | 333 (75.7%) | 282 (75.4%) | 225 (77.3%) |
| Birth order | |||
| First-born | 1057 (82.8%) | 892 (82.5%) | 732 (83.3%) |
| Second-born | 166 (13.0%) | 144 (13.3%) | 112 (12.7%) |
| Third-born or higher | 53 (4.2%) | 45 (4.2%) | 35 (4.0%) |
aParticipants with at least one on-time vaccination
bParticipants with at least one delayed vaccination
cThe number of participants exceeds the study’s total number of participants as some children had vaccinations recommended both before and after the COVID-19 declaration of emergency
dParent-reported wheezing, prematurity, allergy, and atopic dermatitis
Missing data are attributable to self-reported survey data
Fig. 1Participant flow diagram
Vaccination characteristics
| All vaccinations, | On-time vaccinations, | Delayed vaccinations, | |
|---|---|---|---|
| Number of vaccinations | 6937 | 4458 | 2479 |
| Median time to vaccination (days)a | |||
| Before March 17, 2020 | 5 (4, 5) | 2 (2, 2) | 8 (7, 8) |
| After March 17, 2020 | 17 (12, 22) | 10 (3, 14) | 44 (36, 58) |
| Age of scheduled vaccination (months) | |||
| 2 | 1134 (16.4%) | 908 (20.4%) | 226 (9.1%) |
| 4 | 1404 (20.2%) | 963 (12.6%) | 441 (17.8%) |
| 6 | 868 (12.5%) | 550(12.3%) | 318 (12.8%) |
| 12 | 2098 (30.2%) | 1229 (27.6%) | 869 (35.1%) |
| 15 | 807 (11.6%) | 465 (10.4%) | 342 (13.8%) |
| 18 | 626 (9.0%) | 343 (7.7%) | 283 (11.4%) |
| Vaccine type | |||
| DTaP-IPV-Hib | 1982 (28.6%) | 1290 (28.9%) | 692 (27.9%) |
| Pneu-C-13 | 1539 (22.2%) | 1018 (22.8%) | 521 (21.0%) |
| Rot-5 | 1203 (17.3%) | 848 (19.0%) | 355 (14.3%) |
| Men-C–C | 703 (10.1%) | 417 (9.4%) | 286 (11.5%) |
| MMR | 703 (10.1%) | 422 (9.5%) | 281 (11.3%) |
| Var | 807 (11.6%) | 461 (10.3%) | 346 (13.9%) |
| Clinic site | |||
| Clinic site 1 | 664 (9.6%) | 505 (11.3%) | 159 (6.4%) |
| Clinic site 2 | 872 (12.6%) | 626 (14.0%) | 246 (9.9%) |
| Clinic site 3 | 1060 (15.3%) | 723 (16.2%) | 337 (13.6%) |
| Clinic site 4 | 272 (3.9%) | 159 (3.6%) | 113 (4.6%) |
| Clinic site 5 | 630 (9.1%) | 354 (7.9%) | 276 (11.1%) |
| Clinic site 6 | 183 (2.6%) | 127 (2.8%) | 56 (2.3%) |
| Clinic site 7 | 1552 (22.4%) | 890 (20.0%) | 662 (26.7%) |
| Clinic site 8 | 1120 (16.1%) | 703 (15.8%) | 417 (16.8%) |
| Clinic site 9 | 584 (8.4%) | 371 (8.3%) | 213 (8.6%) |
aMedian time to vaccination reported as [median (95% confidence interval)]
Fig. 2Kaplan–Meier curve for time to vaccination. The curve is stratified based on vaccinations recommended before and after Ontario’s COVID-19 declaration of emergency